Manipal Hospital Yelahanka Unites Immunology and Transplant Medicine in Landmark Summit
Event summary
- Manipal Hospital Yelahanka hosted the Immuno-Transplant Summit on April 25-26, 2026, focusing on primary immunodeficiencies and bone marrow transplantation.
- Over 200 delegates from diverse regions and 15 national experts participated, along with international faculty.
- The hospital has treated over 550 patients with immunodeficiencies and performed a significant number of transplants.
- Manipal Hospital Yelahanka was recognized as a Centre of Excellence in immunology and BMT by the Immune Deficiency Foundation (USA).
The big picture
The summit underscores a strategic shift towards integrated, multidisciplinary care in immunology and transplant medicine, addressing a critical gap in early diagnosis and treatment of primary immunodeficiencies. Manipal Hospital Yelahanka's recognition as a Centre of Excellence positions it as a key player in this evolving landscape, potentially influencing healthcare standards and practices in India and beyond.
What we're watching
- Diagnostic Advancements
- How advances in molecular genetics will improve early identification and treatment of immunodeficiencies.
- Specialized Capabilities
- Whether Manipal Hospital Yelahanka can sustain its leadership in immune-related transplants amid growing competition.
- Regulatory Evolution
- The pace at which structured screening programs for immunodeficiencies will be adopted in India.
Related topics